To explore the consequences of S1P in psoriasis pathogenesis and the potential therapeutic relevance of modulating S1P receptors, we utilized FTY720, a pan-S1PR modulator approved for the treatment of multiple sclerosis [17]. The gene discussed is MBTPS1; the disease is multiple sclerosis.